(Q37905890)

25 August 2017

1 reference

title

Pathomechanisms of nephrogenic systemic fibrosis: new insights (English)

1 reference

nephrogenic systemic fibrosis

25 August 2017

main subject

1 reference

A Gupta

1

1 reference

25 August 2017

M K Shamseddin

series ordinal

2

1 reference

25 August 2017

A Khaira

series ordinal

3

1 reference

25 August 2017

publication date

25 July 2011

1 reference

Clinical and Experimental Dermatology

25 August 2017

published in

1 reference

25 August 2017

volume

36

1 reference

25 August 2017

issue

7

1 reference

25 August 2017

page(s)

763-768

1 reference

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Nephrogenic fibrosing dermopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

New insights into nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Decorin is significantly overexpressed in nephrogenic systemic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2011.04136.X

10.1111/J.1365-2230.2011.04136.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference